InvestSMART

Telix Pharmaceuticals Limited (ASX: TLX) - Announcements

- Current share price for TLX : $15.550

ASX company news and announcements for Telix Pharmaceuticals Limited (TLX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Telix Pharmaceuticals Limited (TLX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Telix Pharmaceuticals Limited (TLX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Telix Pharmaceuticals Limited (TLX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$5,285 FDA Accepts Telix NDA for New Prostate Cancer Imaging Agent 24 Jul 2024 9:28AM $20.310 $15.550 fallen by 23.44%
$5,285 Appendix 3B 24 Jul 2024 9:04AM $20.310 $15.550 fallen by 23.44%
$5,285 Telix Successfully Prices A$650M Convertible Bonds 24 Jul 2024 8:57AM $20.310 $15.550 fallen by 23.44%
$5,285 Telix Investor Presentation July 2024 23 Jul 2024 4:59PM $20.310 $15.550 fallen by 23.44%
$5,285 Telix Announces A$600 Million Convertible Bonds Offering 23 Jul 2024 4:57PM $20.310 $15.550 fallen by 23.44%
$5,285 Telix Q2 2024 Revenue/Business Highlights, Guidance Upgrade 18 Jul 2024 8:32AM $20.000 $15.550 fallen by 22.25%
$5,285 CMS proposes payment improvement for radiopharma diagnostics 11 Jul 2024 9:49AM $17.550 $15.550 fallen by 11.40%
$5,285 Notification of cessation of securities - TLX 10 Jul 2024 8:23AM $18.000 $15.550 fallen by 13.61%
$5,285 Cleansing Notice 4 Jul 2024 8:26AM n/a $15.550 n/a
$5,285 Application for quotation of securities - TLX 4 Jul 2024 8:26AM n/a $15.550 n/a
$5,285 Ceasing to be a substantial holder 3 Jul 2024 1:20PM n/a $15.550 n/a
$5,285 Ceasing to be a substantial holder from MUFG 3 Jul 2024 12:37PM n/a $15.550 n/a
$5,285 Pending Release of Shares from Voluntary Escrow 3 Jul 2024 8:24AM n/a $15.550 n/a
$5,285 Ceasing to be a substantial holder 2 Jul 2024 6:47PM n/a $15.550 n/a
$5,285 Ceasing to be a substantial holder 2 Jul 2024 6:46PM n/a $15.550 n/a
$5,285 Ceasing to be a substantial holder from MS 2 Jul 2024 6:25PM n/a $15.550 n/a
$5,285 Ceasing to be a substantial holder 2 Jul 2024 5:28PM n/a $15.550 n/a
$5,285 Cleansing Notice 27 Jun 2024 8:32AM $18.910 $15.550 fallen by 17.77%
$5,285 Application for quotation of securities - TLX 27 Jun 2024 8:31AM $18.910 $15.550 fallen by 17.77%
$5,285 Appendix 3Y Change in Director Interests - C Behrenbruch 27 Jun 2024 8:20AM $18.910 $15.550 fallen by 17.77%
$5,285 Notification regarding unquoted securities - TLX 27 Jun 2024 8:19AM $18.910 $15.550 fallen by 17.77%
$5,285 Telix Elects to Withdraw from Proposed U.S. Listing 14 Jun 2024 8:52AM $16.460 $15.550 fallen by 5.53%
$5,285 Trading Halt 13 Jun 2024 8:31AM $16.460 $15.550 fallen by 5.53%
$5,285 Telix Launches Proposed US IPO 6 Jun 2024 8:21AM $17.890 $15.550 fallen by 13.08%
$5,285 Telix Completes TLX250-CDx (Zircaix) BLA Submission 3 Jun 2024 8:21AM $18.150 $15.550 fallen by 14.33%

276 - 300 of 965 results

Page 12 of 39

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.